{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T21:15:31Z","timestamp":1766870131829,"version":"3.37.3"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006311","name":"Institut National de la Transfusion Sanguine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006311","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011234","name":"Bio-Rad Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011234","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015302","name":"Ortho Clinical Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015302","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.tracli.2019.05.001","type":"journal-article","created":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T15:33:38Z","timestamp":1557588818000},"page":"257-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Anti-HBc prevalence among Croatian blood donors in a 14-year period (2004\u20132017): Assessment of trends, risks and need for implementing routine testing"],"prefix":"10.1016","volume":"26","author":[{"given":"Manuela","family":"Mileti\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasna","family":"Bingulac-Popovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miljana","family":"Stoji\u0107 Vidovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"He\u0107imovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirka","family":"Berendika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Babi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesna","family":"\u0110ogi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marko","family":"Samard\u017eija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karmela","family":"Bari\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irena","family":"Juki\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivanka","family":"Mihaljevi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2019.05.001_bib0105","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jhep.2009.05.020","article-title":"Transfusion-transmitted hepatitis B virus infection","volume":"51","author":"Candotti","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.tracli.2019.05.001_bib0110","unstructured":"WHO, 2017; Global Status Report on Blood Safety and Availability 2016. Available from: https:\/\/apps.who.int\/iris\/bitstream\/10665\/254987\/1\/9789241565431-eng.pdf."},{"key":"10.1016\/j.tracli.2019.05.001_bib0115","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jhep.2008.07.014","article-title":"Statements from Taormina expert meeting on occult hepatitis B virus infection","volume":"49","author":"Raimondo","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.tracli.2019.05.001_bib0120","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199712113372406","article-title":"Hepatitis B virus infection","volume":"337","author":"Lee","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2019.05.001_bib0125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.0042-9007.2004.00406.x","article-title":"Occult Hepatitis B virus infection; implication in transfusion","volume":"86","author":"Allain","year":"2004","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2019.05.001_bib0130","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1537-2995.2011.03283.x","article-title":"Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?","volume":"52","author":"Stramer","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.05.001_bib0135","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/trf.13819","article-title":"Detection of different categories of hepatitis B virus (HBV) infection in a multi-regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV-DNA testing","volume":"57","author":"Lelie","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.05.001_bib0140","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1111\/j.1537-2995.2007.01396.x","article-title":"Hepatitis virus DNA-positive, Hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood service experience","volume":"47","author":"O\u2019Brian","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.05.001_bib0145","first-page":"99A","article-title":"Incidence of Anti-HBc in the population of Croatian Blood Donors. The AABB 2007 Annual Meeting & TXPO, Anaheim, October 20\u201323, 2007, California","volume":"47","author":"Mihaljevi\u0107","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.05.001_bib0150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.21037\/aob.2017.06.01","article-title":"Global epidemiology of occult HBV infection","volume":"2","author":"Allain","year":"2017","journal-title":"Ann Blood"},{"key":"10.1016\/j.tracli.2019.05.001_bib0155","first-page":"281","article-title":"Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection","volume":"11","author":"Romano","year":"2013","journal-title":"Blood Transfus"},{"key":"10.1016\/j.tracli.2019.05.001_bib0160","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1159\/000457965","article-title":"Three-year experience in NAT screening of blood donors for transfusion transmitted viruses in Croatia","volume":"44","author":"Safic Stanic","year":"2017","journal-title":"Transf Med Hemother"},{"key":"10.1016\/j.tracli.2019.05.001_bib0165","first-page":"41","article-title":"HBV-OBI look-back pro and contra?","volume":"107","author":"Mihaljevic","year":"2014","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2019.05.001_bib0170","unstructured":"ISBT TTID Working Party \u201cHBV safety\u201d study-group. Characterization of \u201coccult\u201d HBV yield cases identified by NAT (ID or small pool) or anti-HBc screening. Available from: http:\/\/www.isbtweb.org\/fileadmin\/user_upload\/files-2015\/ttid\/Virology\/HBV%20Safety\/HBV%20Safety%20presentations\/occult%20HBV%20yield%20cases%20by%20ID-NAT%20or%20anti-HBc%20screening%20HBV%20Safety%20protocol%20TTID.pdf."},{"key":"10.1016\/j.tracli.2019.05.001_bib0175","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/0973-6247.95043","article-title":"Hepatitis B core antibody testing in Indian blood donors: a double-edged sword!","volume":"6","author":"Makroo","year":"2012","journal-title":"Asian J Transf Sci"},{"key":"10.1016\/j.tracli.2019.05.001_bib0180","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10096-013-1930-9","article-title":"Surface antigen-negative hepatitis B virus infection in Dutch blood donors","volume":"33","author":"Lieshout-Krikke","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.tracli.2019.05.001_bib0185","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1537-2995.2007.01276.x","article-title":"Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program","volume":"47","author":"Satake","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.05.001_bib0190","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/vox.12198","article-title":"Blood service medical services lookback team. Infectivity of blood components from donors with occult hepatitis B infection\u00a0\u2013\u00a0results from an Australian lookback programme","volume":"108","author":"Seed","year":"2015","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2019.05.001_bib0195","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/trf.12096","article-title":"Infectivity of blood products from donors with occult hepatitis B virus infection","volume":"53","author":"Allain","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.05.001_bib0200","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.3748\/wjg.v22.i13.3531","article-title":"Genetic variation of occult hepatitis B virus infection","volume":"22","author":"Zhu","year":"2016","journal-title":"World Gastroenterol"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S124678201930059X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S124678201930059X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:30:24Z","timestamp":1715596224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S124678201930059X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S124678201930059X"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2019.05.001","relation":{},"ISSN":["1246-7820"],"issn-type":[{"type":"print","value":"1246-7820"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-HBc prevalence among Croatian blood donors in a 14-year period (2004\u20132017): Assessment of trends, risks and need for implementing routine testing","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2019.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Soci\u00e9t\u00e9 fran\u00e7aise de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}